Aldeyra Therapeutics, Inc. (ALDX)
1.22
-0.13
(-9.63%)
USD |
NASDAQ |
Sep 24, 16:00
1.29
+0.07
(+5.74%)
Pre-Market: 08:55
Aldeyra Therapeutics Cash and Short Term Investments (Quarterly) : 45.09M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.09M |
| March 31, 2026 | 65.00M |
| December 31, 2025 | 70.04M |
| September 30, 2025 | 75.30M |
| June 30, 2025 | 81.92M |
| March 31, 2025 | 90.06M |
| December 31, 2024 | 101.15M |
| September 30, 2024 | 72.74M |
| June 30, 2024 | 80.33M |
| March 31, 2024 | 83.04M |
| December 31, 2023 | 142.82M |
| September 30, 2023 | 143.33M |
| June 30, 2023 | 151.68M |
| March 31, 2023 | 165.03M |
| December 31, 2022 | 174.30M |
| September 30, 2022 | 163.83M |
| June 30, 2022 | 117.69M |
| March 31, 2022 | 151.87M |
| December 31, 2021 | 104.79M |
| September 30, 2021 | 116.37M |
| June 30, 2021 | 124.74M |
| March 31, 2021 | 88.44M |
| December 31, 2020 | 52.86M |
| September 30, 2020 | 71.18M |
| June 30, 2020 | 56.19M |
| Date | Value |
|---|---|
| March 31, 2020 | 38.38M |
| December 31, 2019 | 45.36M |
| September 30, 2019 | 50.17M |
| June 30, 2019 | 37.46M |
| March 31, 2019 | 43.12M |
| December 31, 2018 | 93.60M |
| September 30, 2018 | 35.14M |
| June 30, 2018 | 41.68M |
| March 31, 2018 | 38.94M |
| December 31, 2017 | 42.95M |
| September 30, 2017 | 47.91M |
| June 30, 2017 | 25.82M |
| March 31, 2017 | 31.21M |
| December 31, 2016 | 24.91M |
| September 30, 2016 | 28.88M |
| June 30, 2016 | 32.55M |
| March 31, 2016 | 23.03M |
| December 31, 2015 | 27.59M |
| September 30, 2015 | 30.62M |
| June 30, 2015 | 33.57M |
| March 31, 2015 | 15.72M |
| December 31, 2014 | 8.527M |
| September 30, 2014 | 10.14M |
| June 30, 2014 | 11.54M |
| March 31, 2014 | 2.146M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.86M |